GGrantIndex
← Leaderboards

Peter John Meikle

University Of Texas Rio Grande Valley

$3,330,059
Attributed
$7,969,539
Total exposure
4
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,969,539 · 4

By mechanism

R01$7,969,539 · 4

Top collaborators

Most similar at University Of Texas Rio Grande Valley

Same institution · by research overlap

Others in their field

Top investigators on “Cohort

Research focus

CohortGeneticPlasmaLipidsLipid MetabolismSamplingPreventionPathway InteractionsDrug TargetingDisease SusceptibilityGenotypeRisk FactorsPathogenesisVariantCellsGenesPathologyMetabolicLipidomeNovel StrategiesLipidomicsPredispositionAffectLife Style

Grant awards (18)

Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$447,444
R01 · FY2025 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$667,269
R01 · FY2024 · AG
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$500,383
R01 · FY2024 · DK
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$725,129
R01 · FY2023 · AG
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$525,583
R01 · FY2023 · DK
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$369,720
R01 · FY2023 · DK
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$552,650
R01 · FY2022 · DK
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$204,536
R01 · FY2022 · DK
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$589,915
R01 · FY2021 · HL
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$563,496
R01 · FY2021 · DK
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$616,156
R01 · FY2020 · HL
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$567,992
R01 · FY2019 · HL
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$585,642
R01 · FY2018 · HL
Metabolomic studies into the pathogenesis and risk assessment of type 2 diabetes$272,563
R01 · FY2012 · DK · contact PI
Metabolomic studies into the pathogenesis and risk assessment of type 2 diabetes$281,179
R01 · FY2011 · DK · contact PI
Metabolomic studies into the pathogenesis and risk assessment of type 2 diabetes$351,706
R01 · FY2010 · DK · contact PI